Cargando…
Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy.
Autores principales: | Smith, D. B., Newlands, E. S., Spruyt, O. W., Begent, R. H., Rustin, G. J., Mellor, B., Bagshawe, K. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971399/ https://www.ncbi.nlm.nih.gov/pubmed/2138031 |
Ejemplares similares
-
Chemotherapy of advanced malignant teratomas.
por: Newlands, E. S., et al.
Publicado: (1980) -
The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.
por: Crawford, S. M., et al.
Publicado: (1989) -
Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis.
por: Hitchins, R. N., et al.
Publicado: (1989) -
Comparison of ondansetron and combination of ondansetron and dexamethasone as a prophylaxis for postoperative nausea and vomiting in adults undergoing elective laparoscopic surgery
por: Bhattarai, Basant, et al.
Publicado: (2011) -
Bone disease in testicular and extragonadal germ cell tumours.
por: Hitchins, R. N., et al.
Publicado: (1988)